BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26917957)

  • 1. Comorbidities associated with COPD in the Middle East and North Africa region: association with severity and exacerbations.
    Mahboub B; Alzaabi A; Iqbal MN; Salhi H; Lahlou A; Tariq L; El Hasnaoui A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():273-80. PubMed ID: 26917957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE study.
    Koniski ML; Salhi H; Lahlou A; Rashid N; El Hasnaoui A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1685-94. PubMed ID: 26346564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study.
    Uzaslan E; Mahboub B; Beji M; Nejjari C; Tageldin MA; Khan JA; Nafti S; Obeidat NM; Sayiner A; Wali S; Rashid N; El Hasnaoui A;
    Respir Med; 2012 Dec; 106 Suppl 2():S45-59. PubMed ID: 23290704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study.
    Polatli M; Ben Kheder A; Wali S; Javed A; Khattab A; Mahboub B; Iraqi G; Nejjari C; Taright S; Koniski ML; Rashid N; El Hasnaoui A;
    Respir Med; 2012 Dec; 106 Suppl 2():S75-85. PubMed ID: 23290706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE study.
    El Hasnaoui A; Rashid N; Lahlou A; Salhi H; Doble A; Nejjari C;
    Respir Med; 2012 Dec; 106 Suppl 2():S3-15. PubMed ID: 23290702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study.
    Idrees M; Koniski ML; Taright S; Shahrour N; Polatli M; Ben Kheder A; Alzaabi A; Iraqi G; Khattab A; Javed A; Rashid N; El Hasnaoui A;
    Respir Med; 2012 Dec; 106 Suppl 2():S33-44. PubMed ID: 23290703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region.
    Jones PW; Shahrour N; Nejjari C; Lahlou A; Doble A; Rashid N; El Hasnaoui A;
    Respir Med; 2012 Dec; 106 Suppl 2():S86-99. PubMed ID: 23290707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and beliefs about COPD: data from the BREATHE study.
    Sayiner A; Alzaabi A; Obeidat NM; Nejjari C; Beji M; Uzaslan E; Nafti S; Khan JA; Tageldin MA; Idrees M; Rashid N; El Hasnaoui A;
    Respir Med; 2012 Dec; 106 Suppl 2():S60-74. PubMed ID: 23290705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study.
    Tageldin MA; Nafti S; Khan JA; Nejjari C; Beji M; Mahboub B; Obeidat NM; Uzaslan E; Sayiner A; Wali S; Rashid N; El Hasnaoui A;
    Respir Med; 2012 Dec; 106 Suppl 2():S25-32. PubMed ID: 23290701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waterpipe Use in the Middle East and North Africa: Data From the Breathe Study.
    Alzaabi A; Mahboub B; Salhi H; Kajingu W; Rashid N; El-Hasnaoui A
    Nicotine Tob Res; 2017 Nov; 19(11):1375-1380. PubMed ID: 29017260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
    Frantzi N; Nguyen XP; Herr C; Alter P; Söhler S; Soriano D; Watz H; Waschki B; Trinkmann F; Eichenlaub M; Trudzinski FC; Michels-Zetsche JD; Omlor A; Seiler F; Moneke I; Biertz F; Rohde G; Stolz D; Welte T; Kauczor HU; Kahnert K; Jörres RA; Vogelmeier CF; Bals R; Fähndrich S;
    Respir Res; 2024 May; 25(1):207. PubMed ID: 38750572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD in Taiwan: a National Epidemiology Survey.
    Cheng SL; Chan MC; Wang CC; Lin CH; Wang HC; Hsu JY; Hang LW; Chang CJ; Perng DW; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2459-67. PubMed ID: 26648708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019.
    Feizi H; Alizadeh M; Nejadghaderi SA; Noori M; Sullman MJM; Ahmadian Heris J; Kolahi AA; Collins GS; Safiri S
    Respir Res; 2022 Nov; 23(1):319. PubMed ID: 36403049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of the overlap syndrome and its association with comorbidities in patients with chronic obstructive pulmonary disease.
    Steveling EH; Clarenbach CF; Miedinger D; Enz C; Dürr S; Maier S; Sievi N; Zogg S; Leuppi JD; Kohler M
    Respiration; 2014; 88(6):451-7. PubMed ID: 25472034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of comorbidities in COPD clinical control criteria. The CLAVE study.
    Almagro P; Soler-Cataluña JJ; Huerta A; González-Segura D; Cosío BG;
    BMC Pulm Med; 2024 Jan; 24(1):6. PubMed ID: 38166965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting frequent COPD exacerbations using primary care data.
    Kerkhof M; Freeman D; Jones R; Chisholm A; Price DB;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2439-50. PubMed ID: 26609229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.